<DOC>
	<DOC>NCT00793026</DOC>
	<brief_summary>The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.</brief_summary>
	<brief_title>Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: Integral skin test in the region; To use products of the same category; Exclusion criteria: Lactation or gestation; Use of antiinflammatory, antihistaminic or immunosuppressant drugs; Cutaneous disease (local or spread) in the evaluation area; Pathology which may cause immunity depression, such as HIV, diabetes; Endocrine pathology Solar exposure 15 days before evaluation; Treatment until four months before the selection. Allergic or atopic history to cosmetics products The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>